U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT06866132) titled 'Response to an Investigational Device in Patients with Restless Legs Syndrome' on March 03.
Brief Summary: This study assesses the tolerability, safety, and impact of an investigational medical device on restless legs syndrome symptoms.
The IRB has established that the investigational device is non-significant risk.
Study Start Date: March 10
Study Type: INTERVENTIONAL
Condition:
Restless Legs Syndrome
Intervention:
DEVICE: Investigational Noninvasive Neuromodulation Device
The investigational noninvasive neuromodulation device will be setup by the patient at bedtime and will be used every night. The IRB has established tha...